Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin.
Ruether
K
K
Pung
T
T
Kellner
U
U
Schmitz
B
B
Hartmann
C
C
Seeliger
M
M
D000293:Adolescent; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D004596:Electroretinography; D004828:Epilepsies, Partial / Q000188:drug therapy; D006801:Humans; D008297:Male; D012160:Retina / Q000187:drug effects*; D014635:Valproic Acid / Q000627:therapeutic use; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced* / Q000175:diagnosis; D014794:Visual Fields / Q000187:drug effects*; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D014635:Valproic Acid; D020888:Vigabatrin